Home Access' OTC HIV testing service sales may be delayed in California, New York.
This article was originally published in The Tan Sheet
Executive Summary
HOME ACCESS' OTC HIV TESTING SERVICE SALES MAY BE DELAYED in New York and California, two of the largest markets for the product, due to clinical testing requirements in the two states. Home Access Health submitted a request for an "expedited advisory opinion" to FDA on Aug. 16 seeking a determination that the agency's premarket approval of the tests preempts the state requirements.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning